Richard Edmondson

The University of Manchester

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Obstetrics And Gynecology

70%

Biostatistics

50%

Ovarian Cancer

60%

Cancer Biology

50%

Oncology

50%

Gynecologic Oncology

40%

Medical Science

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise

Article Link

Year:

2024

The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome

Article Link

Year:

2023

MDT practice determines treatment pathway for patients with advanced ovarian cancer: A multi-centre observational study

Article Link

Year:

2023

A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer

Article Link

Year:

2023

Is reflex germline BRCA1/2 testing necessary in women diagnosed with non-mucinous high-grade epithelial ovarian cancer aged 80 years or older?

Article Link

Year:

2023

British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer

Article Link

Year:

2023

Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study

Article Link

Year:

2023

Engineering strategies to optimise adoptive cell therapy in ovarian cancer

Article Link

Year:

2023

Optimisation of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer

Article Link

Year:

2023

p53 immunohistochemistry in endometrial cancer

Article Link

Year:

2022

High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer

Article Link

Year:

2022

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

Article Link

Year:

2022

Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study

Article Link

Year:

2022

Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer

Article Link

Year:

2022

Collaborators12

Ranjit Manchanda

Professor of Gynaecological Oncology

UNITED KINGDOM

Carien Creutzberg

Professor of Radiation Oncology

Leiden University Medical Center

NETHERLANDS

Iain McNeish

Imperial College London

UNITED KINGDOM

Carole Cummins

University of Birmingham

UNITED KINGDOM

Marco de Bruyn

Assistant professor

University Medical Center Groningen

NETHERLANDS

Nicola Flaum

The University of Manchester

UNITED KINGDOM

Gordon Jayson

The University of Manchester

UNITED KINGDOM

Thomas Walker

The University of Manchester

UNITED KINGDOM

Laura Woodhouse

The University of Manchester

UNITED KINGDOM

Emma Woodward

Manchester University NHS Foundation Trust

UNITED KINGDOM

Pamela M Pollock

AUSTRALIA

Sudha Sundar

University of Birmingham

UNITED KINGDOM

How do I reach out?

Meet Kite AI